Rebecca Stadel, Ph.D.
|2008||Albany Medical College of Union University|
Mean distance: 30533.1
ParentsSign in to add mentor
ChildrenSign in to add trainee
CollaboratorsSign in to add collaborator
BETA: Related publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.
|Stadel R, Carpenter AB, Nalwalk JW, et al. (2010) Inhibition of brain [(3)H]cimetidine binding by improgan-like antinociceptive drugs. European Journal of Pharmacology. 632: 33-8|
|Stadel R, Yang J, Nalwalk JW, et al. (2008) High-affinity binding of [3H]cimetidine to a heme-containing protein in rat brain. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 36: 614-21|
|Hough LB, Nalwalk JW, Phillips JG, et al. (2007) CC12, a high-affinity ligand for [3H]cimetidine binding, is an improgan antagonist. Neuropharmacology. 52: 1244-55|
|Narayan AV, Stadel R, Hahn AB, et al. (2005) Redox response of the endogenous calcineurin inhibitor Adapt 78. Free Radical Biology & Medicine. 39: 719-27|
|Cannon KE, Nalwalk JW, Stadel R, et al. (2003) Activation of spinal histamine H3 receptors inhibits mechanical nociception. European Journal of Pharmacology. 470: 139-47|
|Hough LB, Nalwalk JW, Stadel R, et al. (2002) Inhibition of improgan antinociception by the cannabinoid (CB)(1) antagonist N-(piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide (SR141716A): lack of obligatory role for endocannabinoids acting at CB(1) receptors. The Journal of Pharmacology and Experimental Therapeutics. 303: 314-22|